300244 迪安診斷
按盤價 
17.490 +0.960 (+5.808%)
17.490 +0.960 (+5.808%) | 2025/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 4,936,485 | -20.61% | 12,196,224 | 13,408,320 | 20,282,469 | 13,082,613 | |
| 減：營業總成本 | 4,643,503 | -18.82% | 11,403,546 | 12,243,282 | 16,603,821 | 11,084,409 | |
| 其中:營業成本 | 3,574,366 | -20.50% | 8,779,607 | 9,213,383 | 12,745,811 | 8,076,949 | |
| 財務費用 | 70,037 | -29.12% | 198,032 | 220,608 | 298,236 | 217,479 | |
| 資產減值損失 | (170) | -93.54% | (401,579) | (16,738) | (624,025) | (272,189) | |
| 公允價值變動收益 | 7,354 | -145.53% | (12,697) | (727) | (56,236) | 83,354 | |
| 投資收益 | 10,703 | 115.56% | 38,713 | (17,596) | 48,787 | 55,338 | |
| 其中：對聯營企業和合營企業的投資收益 | 3,746 | 6.70% | 11,584 | (6,722) | 26,763 | 39,785 | |
| 營業利潤 | 115,853 | -53.26% | (31,115) | 842,183 | 2,822,609 | 1,837,935 | |
| 利潤總額 | 110,800 | -55.04% | (51,826) | 798,326 | 2,543,562 | 1,790,997 | |
| 減：所得稅費用 | 28,597 | -61.25% | 117,407 | 216,735 | 681,092 | 307,396 | |
| 淨利潤 | 82,203 | -52.38% | (169,233) | 581,591 | 1,862,470 | 1,483,601 | |
| 減：非控股權益 | 71,926 | -28.71% | 188,045 | 274,130 | 428,279 | 320,717 | |
| 股東淨利潤 | 10,277 | -85.68% | (357,278) | 307,461 | 1,434,191 | 1,162,884 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.017 | -85.43% | -0.579 | 0.492 | 2.302 | 1.874 | |
| 每股派息 (元) * | -- | -- | 0.900 | 0.060 | 0.200 | 0.135 | |
| 每股淨資產 (元) * | 10.278 | -13.27% | 10.503 | 12.069 | 11.881 | 9.416 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 27/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
